Flowvium

기업 비교

공급망 포지션, 기관 신호, 뉴스 갭 스코어를 나란히 비교합니다.

VS

시가총액 구간

메가vs타이탄

체인 역할

leadervsleader

갭 스코어

38vs5

IB 활동

84vs95

매출 구성 비교

NVO
NVDA
NVO

Novo Nordisk

NVO · pharma-biotech

leader메가 ($100B+)
전체 프로필

소개

Novo Nordisk is the global leader in diabetes care and has become a GLP-1 giant with Ozempic and Wegovy. The obesity-drug revolution has made it Europe's most valuable company. Its near-monopoly on injectable semaglutide positions it at the center of the $100B+ weight-loss drug market.

설립

1923

직원 수

64,000+

본사

Bagsvaerd, Denmark

매출

$42.6B

GLP-1 Diabetes (Ozempic, Rybelsus)42%
Obesity (Wegovy)25%
Insulin20%
Rare Disease & Other13%

뉴스 갭 신호

갭 스코어 (침묵 = 시그널)38
IB 활동 점수84
미디어 커버리지 점수62

IB 활동: HIGH

기관 신호

reducing$163K

BlackRock

2024-08-13

accumulating$200M

BlackRock

2024-08-13

reducing$23M

BlackRock

2024-08-13

핵심 관계

LLY· Eli Lilly and Company
competitor
PFE· Pfizer Inc.
competitor
NVD

NVIDIA Corporation

NVDA · semiconductors

leader타이탄 ($1T+)
전체 프로필

소개

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

설립

1993

직원 수

32,000+

본사

Santa Clara, California, USA

매출

$130.5B

Data Center78%
Gaming12%
Professional Visualization4%
Automotive & Robotics4%
OEM & Other2%

뉴스 갭 신호

갭 스코어 (침묵 = 시그널)5
IB 활동 점수95
미디어 커버리지 점수98

IB 활동: HIGH

기관 신호

accumulating$6.2B

BlackRock

2024-08-13

accumulating$2.8B

BlackRock

2024-08-13

accumulating$3.0B

BlackRock

2024-08-13

핵심 관계

TSM· Taiwan Semiconductor Manufacturing Company
supplier
005930.KS· Samsung Electronics
supplier
000660.KS· SK Hynix
supplier
MU· Micron Technology
supplier
MSFT· Microsoft Corporation
customer